Activation of the immune system requires that the presence of an incipient infection first be detected. This essential step is carried out by tissue macrophages, which alert innate immunity, and by dendritic cells whih alert the adaptive immune system. Both of these sentinel cell types are derived from circulating precursors known as blood monocytes. Here we briefly review current work which has recently expanded our understanding of the origin of blood monocytes and of the factors governing their further differentiation into tissue sentinels.
In the last few years, it has become increasingly clear that bacterial lipopolysaccharide (LPS) can influence many different cell types and that these interactions are of central importance both to tissue homeostasis and to our ability to mount a regulated immune response. Though LPS mediated effects on T-regulator cells, 1 on B-cells 2 and on gut epithelium 3 have all been recently documented, by far the best understood biologically relevant LPS effect remains its ability to activate macrophages and dendritic cells (DCs). This interaction is one of the means by which these mononuclear phagocytes detect a Gram-negative bacterial infection and set an appropriate immune response in motion. Though the nature of these sentinel cells of the immune system has long been the subject of controversy, recent work has started to shed light on their origin and differentiation. In this brief review, it will not be possible to cover this rapidly expanding field in its entirety and instead certain areas in which substantial progress has recently been made will be highlighted.
The first major group of mononuclear phagocytes are the tissue macrophages. Cells which may be described as macrophages range in form from the osteoclasts of bone to the Kupffer cells of the liver or to the microglial cells of the nervous system. Though the various types of tissue macrophages each have their specialised functions, all contribute to tissue homeostasis by removing dead cells and other debris formed either as a result of natural turnover of the tissue or as a consequence of injury. In addition they have a central role to play in immune defence by detecting infectious agents with the aid of their surface receptors such as the TLR molecules whose interaction with microbial ligands leads to an inflammatory response. 4 The inflammatory response involves the release by the activated macrophages of mediators which, in turn, activate the endothelial cells lining the neighbouring capillaries and by doing so facilitate the recruitment from the bloodstream of granulocytes -the major phagocytic effector cells of innate immunity.
The second major group of mononuclear phagocytes are the DCs. Tissue DCs are functionally distinct from macrophages in that their principal role is to serve as antigen-presenting cells which interact with T-cells so as to induce or modulate an adaptive immune response. 5, 6 The immature phagocytic DCs in tissues may be activated by microbial products or by inflammatory cytokines to differentiate into mature non-phagocytic DCs which enter the lymph, migrate to draining lymph nodes, and, once there, present antigen to naive T-cells. As with macrophages, numerous subpopulations of DCs with a wide diversity of function exist, though only recently have these become experimentally tractable. 7 While the analysis of the many functionally important subsets of macrophages and DCs is still in its infancy, recent work using a number of different approaches has begun to shed light on the origin and differentiation potential of their immediate precursors -the blood monocytes.
Bone marrow stem cells
All lymphoid, myeloid and erythroid cells of the blood are products of the haematopoietic stem cells (HSCs) which reside in the bone marrow. These HSCs give rise to populations of daughter stem cells which show both a loss of self-renewal capacity and a progressive restriction of their lineage options. The various stem cell stages can be recovered from the bone marrow by FACS sorting using reagents specific for particular surface markers. The developmental potential of the recovered cell populations may then be determined using in vitro culture systems. The advantage of this form of analysis is that protocols have been developed which permit the determination of developmental capacity at the level of single stem cells. The disadvantage of this approach is that the range and nature of the differentiated products obtained is dependent on the culture conditions, in particular on the feeder cells used and on the cytokine milieu of the medium. Because of this, the information as to the developmental potential of the stem cells which the in vitro experiments provide may -or there again may notreflect what they are actually capable of doing in vivo.
An alternative analysis strategy is to determine the developmental potential of isolated stem cell populations in vivo. This makes use of the fact that the bone marrow stem cell populations are radiation sensitive and, in a mouse, will be ablated by a dose of 950 Rad. Such lethally irradiated animals can, however, be rescued if they are injected with functional stem cells and this forms the basis of an in vivo reconstitution assay. Typically, pooled CD45.1 + bone marrow cells are transferred into lethally irradiated CD45.1 animals to ensure efficient reconstitution and, at the same time, a low number (typically 10 3 -10 5 ) of purified stem cells derived from CD45.2 animals are co-transferred. Because the CD45 gene product is expressed on all the lymphoid and myeloid cells in the blood (though sadly, not on the platelets or erythrocytes), it can be used to determine unambiguously which leukocyte populations were derived in vivo from the purified CD45.2 stem cell population. In this approach, the interpretation of the data depends heavily on how homogeneous the starting stem cell population was and that, in turn, is dependent on the markers used for the isolation. Since different laboratories tend to use different markers, a certain degree of confusion in the literature is inevitable. 8 Using these approaches, it has been shown that a small population of 'lineage negative' (Lin -) bone marrow cells which do not express markers typical of any of the differentiated end products but instead do express the Sca1 protein (spinal cerebellar ataxia 1) and c-kit, the receptor for stem cell factor, have the capacity to produce the full range of differentiated myeloid, lymphoid and erythroid end products in vivo. This Lin -, Sca1 + , ckit + (LSK) population can be further divided into two subpopulations, one of which LSK Flt3is able to provide long-term reconstitution of lethally irradiated recipients while the LSK Flt3 + population has limited renewal capacity and reconstitutes for a period of only 6-8 weeks. 9 Beyond this so-called 'short-term HSC', the cells of the stem cell lineage show a markedly reduced capacity for extended self renewal and become progressively restricted in the range of differentiated products to which they can give rise. The first step is thought to be achieved by the development of a megakaryocyte/erythroid progenitor (MEP) which is restricted to the production of erythrocytes and platelets. 10 The second major lineage division is reached with the establishment of a common lymphoid progenitor (CLP) which can give rise to lymphocytes but not to macrophages or granulocytes 11 and a complementary common myeloid progenitor (CMP) which can give rise to macrophages and granulocytes but not to lymphocytes. 12 These two stem cell populations can be cleanly separated from each other because the CLP expresses the IL-7R α-chain while the CMP does not.
The different developmental options available to the CMP and to the CLP is reflected in the pattern of transcription factors which they produce and this pattern is central to defining the fate of the cells' progeny. As a result, in situations in which the expression of the appropriate transcription factors is interfered with, the lineage assignment may break down. For example, pro-B lymphocytes, which are products of the CLP, normally express the transcription factor Pax5 and are fated to mature only into B-cells. If, however, Pax5 cannot be expressed then both in vitro and in vivo the pro-B cells with their re-arranged IgH locus can back-track within the lymphoid lineage and become T-cells. Indeed, in vitro, and even to a limited extent in vivo, these cells are able to switch lineages, adopt a myeloid fate and become granulocytes or osteoclasts. [13] [14] [15] There is, therefore, a considerable degree of potential plasticity in the system and yet, under normal circumstances, lymphocytes derive only from the CLP while monocytes/macrophages and granulocytes derive exclusively from the CMP.
In this regard, however, DCs are something of a problem for they can be progeny either of the myeloid or of the lymphoid lineage. Initially, the possibility of deriving DCs from both the myeloid and from the lymphoid lineages was thought to provide an elegant explanation for the existence of 'myeloid' (CD8α -) and 'lymphoid' (CD8α + ) DC populations. However, a comparison of the ability of CLPs and of CMPs to generate DCs in vivo showed that each of these populations was able to produce both types of DC and, on a per cell basis, did so with roughly equal efficiency. In addition, both CMP and CLP are able to produce the third type of DC -the plasmacytoid DC -which is distinguished by its ability to produce large amounts of type 1 interferons when activated. Nevertheless, the frequency of CMPs in bone marrow is roughly 10-fold higher than the frequency of CLPs; hence, one would expect that the majority of splenic DCs and at least around half of all thymic DCs are normally derived from the common myeloid progenitors. [16] [17] [18] More recently, the myeloid precursor pool has been screened for cells expressing the chemokine receptor CX3CR1, a molecule which is widely expressed on monocytes, macrophages and DCs. 19 This search was made possible by the construction of a mouse strain in which the gene coding for CX3CR1 was replaced with a copy of the gene coding for 'green fluorescent protein' (GFP). 20 In animals carrying one wild-type allele and one 'knock-in' allele (CX3CR1 +/GFP ), a Lin -, c-kit + , CX3CR1 + subset of the c-kit + , Sca1 -, IL-7Rα -CMP population was shown in in vivo reconstitution experiments to be able to generate several subsets of tissue macrophages as well as both CD8α + and CD8α -DCs. They were, however, not able to produce granulocytes and hence are more restricted in their differentiation potential than the CMP. As expected of a subset within the CMP population, these cells did not give rise to lymphoid or erythroid products.
Differentiation of myeloid lineages in vitro
The monocytes which derive from the CMP serve as a progenitor pool from which both tissue macrophages and DCs can develop. 19, 21 One of the central puzzles concerning these cells is how the decision as to their direction of differentiation is reached. Part of the answer has come from in vitro differentiation studies in which cultures of bone marrow cells are supplemented with various cytokines. The cytokine M-CSF is usually required to stimulate differentiation of macrophages from bone marrow cells in vitro though it is generally not required for the maturation of DCs. On the other hand, GM-CSF or the ligand for the receptor tyrosine kinase Flt3 stimulate the in vitro differentiation of many DC subsets but not of macrophages.
If the cultures are supplemented with GM-CSF and IL-4, they yield cells with a phenotype resembling that of immature DCs which can then be further induced to acquire properties associated with mature DCs by the addition of TNF-α. 6 By altering the mix of cytokines added to the culture system, cells with different phenotypes can be generated. Thus, in medium containing GM-CSF and IL-15, DCs which show some, but not all, of the phenotypic features of Langerhans cells are generated. 22 Supplementing the cultures with IL-15 alone yields cells resembling tissue macrophages 23 as also happens with monocytes cultured in the presence of IL-6. 24 IL-4 and IL-13, on the other hand, push differentiation in the direction of alternatively activated macrophages (M2 type macrophages) which are hyporesponsive to LPS. 25, 26 These in vitro culture systems have proven enormously useful in defining the phenotypes and properties of the differentiated products as well as in the analysis of the molecular control of the differentiation process. 23, 27, 28 However, such systems do suffer from the drawback that they may only reflect a part of what is going on in vivo. Thus, for example, the differentiation of monocytes into DCs in inflamed tissue in vivo takes less than 18 h, 21 while differentiation to DCs in most in vitro culture systems requires around 7 days. 6 Simple mixes of soluble cytokines alone are not the whole story -cellular interactions may also be important in directing the differentiation of the monocytes.
The first direct cell-cell interaction involving the blood monocytes is their encounter with the endothelial cells which line the blood vessels, for the monocytes must establish contact with them in order to exit from the blood and gain access to the underlying tissue. This process of extravasation of the monocytes follows the well-established paradigm in which an initial selectinbased interaction is followed by a chemokine-induced activation of integrins to bring the cell into close contact with the endothelium. 29 The monocytes then pass between the endothelial cells to enter the underlying tissue. This process is currently the subject of intensive research, and the broad outlines are becoming clear. [30] [31] [32] [33] [34] [35] [36] However, up until now, these approaches have perhaps been more informative about the molecular processes involved in the monocyte penetration of the tight junctions between the endothelial cells and have, so far, yielded little information as to how this extravasation process may influence monocyte development.
While macrophages may remain in the tissue for the remainder of their life, activated DCs re-cross an endothelial layer by 'reverse transmigration' to enter the lymph and migrate towards the nearest draining lymph node. Some aspects of these processes have been modelled in a sophisticated in vitro culture system in which endothelial cells are grown on a collagen layer that contains yeast cell wall particles (zymosan) which are avidly taken up by phagocytic cells. 37 Blood monocytes added to this culture system first migrate through the endothelial cell layer into the underlying collagen but, over the course of the subsequent two days, around half of the cells re-migrated back through the endothelial cell layer. Around half of those cells which underwent this reverse transmigration expressed typical phenotypic markers of DCs while the cells that remained in the collagen layer expressed typical macrophage markers. Furthermore, since the development of DCs after reverse migration was dependent on the presence of zymosan in the collagen layer, the extent of monocyte differentiation to macrophages or DCs can clearly be modulated by external signals. However, only an in vivo analysis can tell us how these processes are actually regulated.
Differentiation in vivo: release of monocytes from the bone marrow
It is at present unclear how the release of the monocytes generated in the bone marrow from the CMP is effected and controlled. However, recent data suggest that this step is regulated, at least in part, by chemokine-chemokine receptor interactions. This emerged from an analysis of a Listeria infection model in the mouse in which control of the infection in the spleen requires the presence of a population of TNF and iNOS producing DCs which differentiate from CD11b + , Ly6C + , CCR2 + monocytes. Animals in which the CCR2 gene has been knocked out are unable to control the infection and die. Since CCR2 is a receptor for the pro-inflammatory chemokine MCP-1 (monocyte chemo-attractant protein 1), one might expect that it is required in order that circulating monocytes can locate the site of infection. Surprisingly, this was not the case since CCR2 -/monocytes injected intravenously were as effective as CCR2 +/+ monocytes in reaching the spleen and controlling the infection. Instead the problem in CCR2-deficient mice is that the monocytes are unable to leave the bone marrow. In these CCR2 -/animals, the population of monocytes does expand in response to the infection but the cells are trapped in the bone marrow and do not reach the circulation. 38 It will be of great interest to learn whether the release of different monocyte populations involve different specific chemokine-chemokine receptor interactions.
Blood monocytes
Once released from the bone marrow blood, monocytes are transiently present in the circulation as they disperse to the peripheral tissues where they complete their differentiation into macrophages or DCs. Early work demonstrated that both in the rat 39 and in the mouse 40 circulating monocytes are a population of non-dividing cells which, in the mouse, remain in the circulation with an average retention time of 32 h before exiting into the periphery. 40 Nevertheless, much remains to be discovered about the nature and complexity of blood monocyte populations. Part of the difficulty in this regard may stem from the fact that 'monocytes' are operationally defined by the markers used to identify them and different markers may detect somewhat different cell populations.
There is, indeed, unambiguous evidence that human blood monocytes are not a homogeneous cell population. In normal healthy human volunteers, around 10% of circulating monocytes express the FcγRIII (CD16). 41 This population is greatly expanded in patients with sepsis 42 and reduced during treatment with glucocorticoids. 43 CD16 + monocytes can be generated in vitro by culturing the CD16population in the presence of TGFβ1, 44 though whether this reflects their mode of generation in vivo remains to be established. In the in vitro reverse transmigration assay referred to above, the CD16 + monocyte population preferentially gave rise to DC-like cells suggesting that the different monocyte subpopulations may have different developmental preferences and capacities in the periphery. However, the in vivo relevance of these two monocyte populations remained unclear.
The demonstration of heterogeneity within the monocyte population with respect to the expression of chemokine receptors has turned out to be a much more revealing approach. Like lymphocytes and granulocytes, the final goal of monocytes is determined by the homing system in which the correct 'address' for the cell is defined in part by a chemokine-chemokine receptor interaction. 29, 45 Because of this, monocytes with different patterns of chemokine receptors may have different target tissues and, hence, different functions. The in vivo relevance of differences in chemokine receptor expression was demonstrated in an elegant study which made use of the mouse strain in which a copy of the gene coding for green fluorescent protein was transferred by homologous recombination into the CX3CR1 locus. 20 CX3CR1 is a chemokine receptor which interacts with the membrane-tethered chemokine fractalkine present on normal endothelial cells. In heterozygous mice carrying one copy of the fractalkine receptor CX3CR1 and one 'knock-in' allele (CX3CR1 +/GFP ), all of the blood monocytes, defined as the CD11b + , F4/80 + leukocytes, expressed the fluorescent transgene. However, there were two populations of these cells. In the first, the GFP gene driven by the CX3CR1 promoter was expressed at a low level (CX3CR1 lo ) while in the second population it was expressed in high amounts (CX3CR1 hi ). To search for similar populations in human monocytes, a labelled fractalkine-Fc fusion protein was used to identify CX3CR1 positive cells in human whole blood. As in the mouse, two populations were identified: The CX3CR1 lo population consists of large CD14 + cells and corresponds to 'classical' monocytes while a CX3CR1 hi population corresponds to the CD16 + monocyte subpopulation. 21 The availability of the CX3CR1 -GFP 'knock-in' mice made an in vivo analysis of the function of these two cell populations possible. This was achieved by injecting isolated GFP-expressing CX3CR1 lo or CX3CR1 hi cells from CX3CR1 +/GFP animals into CX3CR1 +/+ recipients and following the fate of the transferred cells. The CX3CR1 hi subpopulation homed to a wide range of tissues and this pattern was not significantly altered when a peritoneal inflammation was induced in the recipients by intraperitoneal application of thioglycollate. This monocyte population may, therefore, be the source from which normal tissue macrophage loss is replenished. The CX3CR1 lo population, in contrast, appeared to be rapidly lost in normal healthy animals but in thioglycollate treated mice these cells preferentially homed to the inflamed peritoneum where they acquired the DC markers CD11c and MHC class II as well as the functional capacity to prime naive T-cells. 21 This is in agreement with the observation that only the CX3CR1 lo population expresses the CCR2 chemokine receptor for the proinflammatory mediator MCP-1. 46 The ability of this CCR2 + monocyte population to home to sites of inflammation is not limited to the peritoneum since they will also home to peripheral lymph nodes draining sites of intracutaneous inflammation. 46 Furthermore, these CCR2 + monocytes play an important role in reconstituting the Langerhans cells in the epidermis. This specialised DC population forms a network in the skin covering the entire body and provides the first line of defence of the adaptive immune system. In the course of normal turnover, Langerhans cells are replaced from a pool of self-renewing precursors present in the skin; 47 however, after an inflammatory insult, such as UV damage, the resulting loss of the Langerhans cells is made good by replacement from blood monocytes. 48 From these in vivo experiments, a picture emerges in which distinct populations of blood monocytes can be distinguished which may have the capacity to generate different subsets of tissue macrophages and DCs.
Monocyte extravasation in vivo
The availability of the CX3CR1 +/GFP mice has also provided the opportunity to examine the ways in which monocytes respond to different extravasation signals. Cells which had extravasated into the lungs were recovered from broncho-alveolar fluid by FACS sorting and their gene expression pattern compared to that of blood monocytes using cDNA microarrays representing 1176 selected genes. In normal, healthy animals, the monocyte transcriptional program was not greatly altered during extravasation. However, when alveolar inflammation was mimicked by an intratracheal bolus of the pro-inflammatory mediator CCL2 then the number of monocytes moving into the lung increased and they underwent a dramatic change in their transcriptional profile. The recruited cells showed up regulation of genes coding for cell adhesion molecules and for granulocyte chemo-attractants. 49 This approach may pave the way for a detailed analysis of changes in the activation status of monocytes as they make the crucial step from circulating cells to tissue resident effectors.
Modulation of monocyte differentiation
The degree of heterogeneity in the differentiated populations of macrophages and DCs is vastly greater than that so far established for the blood monocytes themselves. This may reflect an as yet unexplored degree of complexity in the monocyte population 19 and/or tissue-specific influences on the differentiation process. This heterogeneity of the differentiated phenotypes can be seen in the varied responses of macrophage populations to LPS. Blood monocytes use the TLR4 receptor to bind LPS 50,51 and this interaction leads to the synthesis and release of copious amounts of many pro-inflammatory mediators. 4, 52 However, not all macrophage types respond to LPS in this way. In particular, the monocytes which exit from the circulation to enter the gut mucosa differentiate into cells which, though they have potent phagocytic and bacteriocidal capacity, lack the receptors for LPS, for complement as well as the Fc receptors for IgG and IgA. As a consequence, these cells fail to produce pro-inflammatory mediators when challenged with bacteria. Making these gut mucosal macrophages insensitive to LPS may be an important adaptation to prevent excessive inflammatory responses in cells living in close proximity to the gut microbial flora. In this case, the anergic inflammatory phenotype may be induced during their final differentiation from monocytes by TGFβ released from mucosal stromal cells. 53 The M2-type macrophages thought to be involved in the resolution of immune responses are, in a similar way, also refractory to stimulation by LPS. 26 LPS itself can influence the differentiation potential of monocytes since subcutaneous injection of LPS or of bacteria has the effect of blocking the differentiation of newly recruited monocytes into dermal DCs. 54 This may be a mechanism which helps to prevent the spread of those pathogens which try to hitch a lift in the DCs and, by doing so, to swarm out from the source of infection. Since this phenomenon was TLR4-dependent, it indicates that TLR engagement in this particular in vivo context regulates the developmental capacity of the monocytes.
Stability of macrophage and DC phenotypes
The range of cell types developed from monocytes and the degree of plasticity evident in the regulation of their development raises the question of the stability of the differentiated phenotypes. Human DCs derived from blood monocytes by culturing in the presence of GM-CSF and IL-4 were shown to be converted into macrophage-like cells by the addition of IL-10. 55 In a similar way, mouse bone marrow derived mature DCs cultured on splenic stromal cells were converted into regulatory dendritic cells which have a phenotype reminiscent of macrophages. 5 On the other hand, the response of both peritoneal and bone marrow derived macrophages to LPS can be modulated by exposure of the cells to various cytokine treatments. 56 However, in contrast to these situations, the 'anergic' phenotype of the macrophages from the gut mucosa appears to be remarkably stable since it can be maintained in culture for an extended period. 53 Determining the extent of lineage complexity in the blood monocyte population, the plasticity of the differentiated phenotypes and the in vivo conditions under which they may transdetermine, will be major tasks for the future.
Outlook
There was a time not so many years ago when lymphocytes were no more than small leukocytes. Since then, a bewildering array of lymphocyte types has been discovered and their functional importance in mounting and regulating immune responses is still being unravelled. We are, perhaps, just at the beginning of a rather similar story as the secrets of monocytes and their differentiated products start to be revealed. Monocytes, macrophages and DCs are surely going to provide food for thought for years to come.
